The incidence of EGFR‐mutant NSCLC is more prevalent in the Asia‐Pacific region (36.8%–51.4%), including Korea, than in the Western regions (7%–22%).14, 23, 24. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.